IMPAKT 2017

Oncology Meeting Resources

04 May - 06 May 2017, Brussels, Belgium

IMPAKT 2017 breast cancer conference

IMPAKT 2017 Breast Cancer Conference was designed for breast cancer researchers and clinicians who have a specific interest in translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting.

Resources from IMPAKT 2017 Breast Cancer Conference are available to ESMO member according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO and BIG thank the authors for their generosity.

Download the IMPAKT 2017 Scientific report

ESMO Scientific videos from IMPAKT 2017

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...-with-TDM1-for-metastatic-HER2-breast-cancer

BodyPURPOSE: HER2+ breast cancer is treated using agents that target the amplified receptor. Such drugs are effective; however, recurrence and progression can occur in spite of multiple HER2-targeted therapies.

Date: 04 May 2017
Presenter: Erik Knudsen
Resources: Abstract
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-2017/Invited-discussant-abstracts-1O-and-2O

Date: 04 May 2017
Presenter: Philippe Bedard
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...or-Retrospective-analyses-of-the-STO-3-trial

BodyBackground It has been suggested that breast cancer tumors possess intra-tumor heterogeneity with varying metastatic capacity. Here, we aimed to determine whether high intra-tumor heterogeneity of...

Date: 04 May 2017
Presenter: Linda Lindström
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...nd-results-from-the-BIG-2-98-phase-III-trial

BodyPurpose: To gain better insight into the prognostic role of the STAT3 signaling pathway in estrogen receptor positive (ER positive) breast cancer, we evaluated the pSTAT3 proteomic and gene signature...

Date: 04 May 2017
Presenter: Amir Sonnenblick
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-HER2-ABC-Efficacy-by-baseline-tumor-markers

BodyBackground: Cyclin D–cyclin-dependent kinase (CDK) 4/6 complexes promote cell proliferation through retinoblastoma protein (Rb) phosphorylation. Cyclin D gene (CCND1) amplification or loss of...

Date: 04 May 2017
Presenter: Fabrice André
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...r-during-pregnancy-and-non-pregnant-controls

BodyBackground: Currently, breast cancer during pregnancy (BCP) is not believed to be biologically different from breast cancer (BC) unrelated to pregnancy based on limited datasets mainly obtained by immunohistochemistry.

Date: 04 May 2017
Presenter: Sibylle Loibl
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...esponse-to-statin-treatment-in-breast-cancer

BodyThe impact of systemic 27-hydroxycholesterol (27HC) and intra-tumoral CYP27A1 expression on pathobiology and clinical response to statins in breast cancer needs clarification.

Date: 04 May 2017
Presenter: Siker Kimbung
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...xpression-following-neoadjuvant-chemotherapy

BodyObjective: The hormone receptor and HER2 expression of a primary breast carcinoma plays a significant role in patient management, treatment and prognosis. The aim of this study was to compare...

Date: 04 May 2017
Presenter: Carolina Ponce
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ose-Vitamin-D-in-Patients-with-Breast-Cancer

BodyBackground: Epidemiologic and preclinical laboratory data suggest that there is a role for vitamin D in breast cancer therapy through its tumor suppressive effects.

Date: 04 May 2017
Presenter: Angel Arnaout
Resources: Abstract
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...s-with-metastases-in-sentinel-lymph-node-SNB

BodyBackground. Despite the progress in research of the breast cancer, lymph node status still remains the main prognostic parameter and the key factor for adjuvant therapy.

Date: 04 May 2017
Presenter: Maria Nagadowska
Resources: Abstract
Topics: Breast Cancer, Surgery and/or Radiotherapy of Cancer